Schuchart Aaron 4
4 · LUMOS PHARMA, INC. · Filed Aug 13, 2021
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
Schuchart Aaron
Chief Business Officer
Transactions
- Purchase
Common Stock
2021-08-11$7.35/sh+300$2,205→ 1,337 total - Purchase
Common Stock
2021-08-12$7.42/sh+1,700$12,614→ 3,037 total
Footnotes (2)
- [F1]Includes 695 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- [F2]Includes 109 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2021.